According to Monte Rosa Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.13 B. In 2023 the company made an earning of -$0.14 B a decrease over its 2022 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.